448
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease

, , , , &
Pages 423-428 | Received 09 Jun 2014, Accepted 02 Jul 2014, Published online: 30 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nina Barner-Rasmussen, Nelli Sjöblom, Johanna Arola, Sonja Boyd, Hannu Kautiainen & Martti Färkkilä. (2023) The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score. Scandinavian Journal of Gastroenterology 58:12, pages 1491-1498.
Read now
Anna-Maija Puolanne, Sami Qadri, Tiina Vesterinen, Saara Hiltunen, Aaro Mustonen, Samu Kurki, Kaija-Leena Kolho, Johanna Arola & Martti Färkkilä. (2022) Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?. Scandinavian Journal of Gastroenterology 57:11, pages 1304-1311.
Read now
Marko Vannas, Martti Färkkilä, Harri Sintonen, Fredrik Åberg & Helena Isoniemi. (2020) Health-related quality of life before and after liver transplantation in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 55:3, pages 347-353.
Read now
Nina Barner-Rasmussen, Eero Pukkala, Airi Jussila & Martti Färkkilä. (2020) Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland. Scandinavian Journal of Gastroenterology 55:1, pages 74-81.
Read now
Seyed Alireza Taghavi, Ahad Eshraghian, Ramin Niknam, Gholam Reza Sivandzadeh & Kamran Bagheri Lankarani. (2018) Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 12:6, pages 575-584.
Read now

Articles from other publishers (21)

Renata D. Peixoto, Artur R. Ferreira, James M. Cleary, João P. Fogacci, João P. Vasconcelos & Alexandre A. Jácome. (2022) Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy. Journal of Gastrointestinal Cancer 54:2, pages 357-367.
Crossref
Mohamed Attauabi, Mads Damsgaard Wewer, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2022) Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflammatory Bowel Diseases 28:11, pages 1756-1765.
Crossref
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Toni Saarela, Andrea Tenca, Johanna Arola, Risto Renkonen & Martti Färkkilä. (2022) Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis. PLOS ONE 17:8, pages e0272810.
Crossref
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh & Mathias Heikenwalder. (2021) Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 7:7, pages 606-623.
Crossref
Rune Erichsen, Ola Olén, Michael C. Sachs, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F. Ludvigsson & Henrik Toft Sørensen. (2021) Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 30:5, pages 886-894.
Crossref
Elena Niccolai, Federico Boem, Giacomo Emmi & Amedeo Amedei. (2020) The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit. Immunology Letters 222, pages 12-28.
Crossref
Mingshi Chen, Caihong Yuan & Tianshu Xu. (2020) An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 44:3, pages 302-309.
Crossref
Igor V. Maev, Yurii A. Shelygin, Maria I. Skalinskaya, Alexey V. Veselov, Ekaterina V. Skazyvaeva, Irina A. Rasmagina, Diana A. Komarova & Igor G. Bakulin. (2020) The pathomorphosis of inflammatory bowel diseases. Annals of the Russian academy of medical sciences 75:1, pages 27-35.
Crossref
Junmin Song, Yang Li, Christopher L. Bowlus, GuoXiang Yang, Patrick S. C. Leung & M. Eric Gershwin. (2019) Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinical Reviews in Allergy & Immunology 58:1, pages 134-149.
Crossref
Zhuwan Lyu, M. Eric Gershwin & Xiong Ma. 2020. Liver Immunology. Liver Immunology 167 178 .
. (2019) UEG Week 2019 Poster Presentations. United European Gastroenterology Journal 7:S8, pages 189-1030.
Crossref
Kang Li & Chaohui He. (2019) Gastric Mucosal Lesions in Tibetans with High-Altitude Polycythemia Show Increased HIF-1A Expression and ROS Production. BioMed Research International 2019, pages 1-11.
Crossref
Walaa Nasry, Juan Rodriguez-Lecompte & Chelsea Martin. (2018) Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers 10:10, pages 348.
Crossref
Özgür M Koc, Roel J W van Kampen & Adriaan A van Bodegraven. (2018) Cancer-Associated Chemotherapy Induces Less IBD Exacerbations and a Reduction of IBD Medication Afterwards. Inflammatory Bowel Diseases 24:7, pages 1606-1611.
Crossref
Jakob Ørskov Sørensen, Ole Haagen Nielsen, Mikael Andersson, Mark Andrew Ainsworth, Henriette Ytting, Erika Bélard & Tine Jess. (2018) Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Liver International 38:3, pages 532-541.
Crossref
Kang Li, Luobu Gesang & Chaohui He. (2017) Mechanism of apoptosis involved in gastric mucosal lesions in Tibetans with high-altitude polycythemia. Experimental and Therapeutic Medicine 14:4, pages 3780-3787.
Crossref
Kang Li, Luobu Gesang, Zeng Dan & Lamu Gusang. (2016) Transcriptome reveals the overexpression of a kallikrein gene cluster (KLK1/3/7/8/12) in the Tibetans with high altitude-associated polycythemia. International Journal of Molecular Medicine.
Crossref
Meibao Feng, Jieqiong Feng, Wuzhen Chen, Wubin Wang, Xuesong Wu, Jing Zhang, Fangying Xu & Maode Lai. (2016) Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Molecular Cancer 15:1.
Crossref
Jordan E Axelrad, Simon Lichtiger & Vijay Yajnik. (2016) Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World Journal of Gastroenterology 22:20, pages 4794.
Crossref
Valery Hrad, Yoftahe Abebe, Syed Haris Ali, Jared Velgersdyk, Mohammed Al Hallak & Mohamad Imam. (2016) Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterology Research and Practice 2016, pages 1-9.
Crossref
Kang Li, Luobu Gesang, Zeng Dan, Lamu Gusang, Ciren Dawa & Yuqiang Nie. (2015) Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury. PLOS ONE 10:10, pages e0140534.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.